{"name":"RIGImmune Inc.","slug":"rigimmune-inc","ticker":"","exchange":"","domain":"rigimmune.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RIG-101","genericName":"RIG-101","slug":"rig-101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"RIG-101","genericName":"RIG-101","slug":"rig-101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQMU1HVkc4YndVNWx4cVJrckltMFhmaGRXTlhNNGNRSDBhQUlTckEwNGxFWHIteGJubktKbExlNjdiYkYwbXlRc0F6d2tWcEFEUDB1WGxsMXF1RFIyQVpFLWt1UWIwMEdaM3lPcnI0blozcl9nNkVlWUhFc3BGemhrYVRObV8yV0hfV2RSazN3MEt5cV9TR3N4Mmt1TDdjenF4aEdfdTF4V01aTVBndVFSUjBR?oc=5","date":"2025-10-14","type":"pipeline","source":"Healio","summary":"Monoclonal antibody effects persist for 6 months in patients - Healio","headline":"Monoclonal antibody effects persist for 6 months in patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPcUVPd3FEZEdqQmI1eUlWLVlpUlhmUzZqeFB4eDdrUnRjSUs5MmZEY3NOc0E0ZVhHOWRvVWdUN3ZQR2pEeHNTc1Awd0JoOXJmMk05azJISVh4cnRVMzZQdjRLRHRVU2daeVN6OUJyOC00dFFUZFpqSzhPaDA3bjNrMV9zZU5CMVlqSzZlbHNGX2J5dlAzZFE?oc=5","date":"2022-10-13","type":"pipeline","source":"Pharma Voice","summary":"Coming out of stealth, RIGImmune aims to catch up with ever-mutating viruses - Pharma Voice","headline":"Coming out of stealth, RIGImmune aims to catch up with ever-mutating viruses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVkVsdEI3UUk2UEpaa1lNMkFIQ1Vvek52clFyNmttX2ZJenJLQTd6SHBmMWlBdGcyYzhHdUx0WkhpeEpoZWlCdlhVZXdLNnkwQnhNU0RiandSNjllUHcwZ1lJMHZkYkVjZm9TTXJJT0pNOTFBXzhxZVhISlBDQUxvSm1zdkVfck8wTXdianYteXJWbTRiTFEwMHBHRTNHQUtOWXpMcWlxRUJiSWp5VHFfWVdHbEkwX1U3?oc=5","date":"2022-09-19","type":"deal","source":"Fierce Pharma","summary":"RIGImmune subsumes Subintro in nasal drug delivery buyout, secures F-Prime investment - Fierce Pharma","headline":"RIGImmune subsumes Subintro in nasal drug delivery buyout, secures F-Prime investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPMEhKaGlDVy05c0h0dG1Wb0NSZHJRaDZBVjk0UHRzYzJYRmNBRklVSjBvTW5IX3hJdV85OVRvT2RTU3h2TWVIQngtTjRzOERZekNrRG9BeVBfNVBHRXNCNV9weGRtazNyeHRNc2s1aVF1VVBHLXp4Um9qdll3QlJnNEJSUDNqcTI3RmtzajdpTdIBlAFBVV95cUxQcUFMcWpCbmkyM3Q5SW5ZNWRlTGE5aWliMkQ3VjFuRGNYdlE3OEZzdGJWZXVEc3haVmxJbTJMVzQtUHNmUG56YTlPVm93clRBLU8wOVRXWUlzclhNMS1hbGVTM1lsR2JTTTlSSUVDVmd4Y2k5enhHX1FIY19SLVNydXpOVTBpemhwRDJlOXZZRmZHSTAt?oc=5","date":"2021-12-10","type":"pipeline","source":"Express Pharma","summary":"Alembic announces seed round investment in RIGImmune, Inc - Express Pharma","headline":"Alembic announces seed round investment in RIGImmune, Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNRm11eVFzcDJaQmdabUYwZWZoRGlIZ19MX2F2bllLTXNFT2w2UGdYWVlQWHc4dGYyd0VZb3dQYUN3aW56RGhJaEhiRHRrVFphd2NKbGVJRXVucmxKNzB2NDNOU0JWY3haTGItSjVWcGt1c1gtZmJBOTVZZUx3MzQ3RnpHTE5JRTY3OGUw0gGQAUFVX3lxTE40NHdBWW4yVlA4ZGpfV0p0aTM3ejd3akJJV04tanBFSkZab3hocHRZMmE4TEdoLU5ZR0x1Z1VUUzhOMFNVZS1vYTUtSlBzY09JemdwbWJIcGdCZFY1R291bXpLbkhpeE5PYXhGNFdGNnpvV0xBSzBVV3pEZUdialRIOFhLMDRObF9wWTRzMHRnNA?oc=5","date":"2021-12-10","type":"pipeline","source":"Express Pharma","summary":"Pharmexcil invites applications for Director position - Express Pharma","headline":"Pharmexcil invites applications for Director position","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}